Guidance and Position Statements

Role and Value of the Corporate Medical Director

12/04/2023 By Gregg Stave, MD, Wayne Burton, MD, Richard J.L. Heron, MB ChB, T. Warner Hudson, MD, J. Brent Pawlecki, MD, David Roomes, MB ChB, Martin Sepulveda, MD, Michael Rendel, MD, Pamela Hymel, MD
The role of the Corporate Medical Director (CMD) has received increased attention during the COVID-19 pandemic and has continued to evolve. This updated guidance addresses the role and value of the CMD in: health policy, strategy, and leadership; fostering a culture of health and well-being; supporting worker health and productivity/ performance; addressing mental health; collaborating on employer benefits design; developing programs for global health, travel medicine, and remote/extreme environments; overseeing on- and near-site clinics; incorporating digital technology, artificial intelligence, and telehealth in health programs; supporting critical incident preparedness and business continuity planning; addressing workplace hazards; and overseeing periodic executive health examinations.
 
Download File
This guidance paper was developed by ACOEM’s Corporate Medicine Section Task Force. It was approved by ACOEM’s Executive Committee on August 17, 2023. ACOEM requires all substantive contributors to its documents to disclose any potential competing interests, which are carefully considered. ACOEM emphasizes that the judgments expressed herein represent the best available evidence at the time of publication and shall be considered the position of ACOEM and not the individual opinions of contributing authors.